Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma The NEOCRTEC(50)10 Randomized Clinical Trial

Yang, H; Liu, H; Chen, YP; Zhu, CC; Fang, WT; Yu, ZT; Mao, WM; Xiang, JQ; Han, YT; Chen, ZJ; Yang, HH; Wang, JM; Pang, QS; Zheng, X; Yang, HJ; Li, T; Zhang, X; Li, Q; Wang, G; Chen, BF; Mao, T; Kong, M; Guo, XF; Lin, T; Liu, MZ; Fu, JH

Fu, JH (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr,Guangdong Esophageal Canc Inst, State Key Lab Oncol South China,Dept Thorac Surg, Guangzhou 510060, Guangdong, Peoples R China.

JAMA SURGERY, 2021; 156 (8): 721

Abstract

IMPORTANCE The prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) remains poor after surgery. Neoadjuvant chemoradi......

Full Text Link